Amphastar Pharmaceuticals Inc (AMPH)
45.46
+0.91
(+2.04%)
USD |
NASDAQ |
Nov 22, 16:00
45.43
-0.03
(-0.07%)
After-Hours: 20:00
Amphastar Pharmaceuticals Debt to Equity Ratio: 0.82 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.82 |
| June 30, 2024 | 0.823 |
| March 31, 2024 | 0.8841 |
| December 31, 2023 | 0.9227 |
| September 30, 2023 | 1.073 |
| June 30, 2023 | 0.8506 |
| March 31, 2023 | 0.1368 |
| December 31, 2022 | 0.1435 |
| September 30, 2022 | 0.1498 |
| June 30, 2022 | 0.1521 |
| March 31, 2022 | 0.1595 |
| December 31, 2021 | 0.1728 |
| September 30, 2021 | 0.1809 |
| June 30, 2021 | 0.0913 |
| March 31, 2021 | 0.1097 |
| December 31, 2020 | 0.1155 |
| September 30, 2020 | 0.1112 |
| June 30, 2020 | 0.1174 |
| March 31, 2020 | 0.1268 |
| December 31, 2019 | 0.1236 |
| September 30, 2019 | 0.1157 |
| June 30, 2019 | 0.1205 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.145 |
| December 31, 2018 | 0.151 |
| September 30, 2018 | 0.1603 |
| June 30, 2018 | 0.1641 |
| March 31, 2018 | 0.1399 |
| December 31, 2017 | 0.1413 |
| September 30, 2017 | 0.1465 |
| June 30, 2017 | 0.1389 |
| March 31, 2017 | 0.1118 |
| December 31, 2016 | 0.1146 |
| September 30, 2016 | 0.13 |
| June 30, 2016 | 0.1387 |
| March 31, 2016 | 0.1358 |
| December 31, 2015 | 0.1391 |
| September 30, 2015 | 0.1625 |
| June 30, 2015 | 0.1663 |
| March 31, 2015 | 0.1734 |
| December 31, 2014 | 0.155 |
| September 30, 2014 | 0.1814 |
| June 30, 2014 | 0.186 |
| March 31, 2014 | 0.165 |
| December 31, 2013 | 0.1279 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0913
Minimum
Jun 2021
1.073
Maximum
Sep 2023
0.3632
Average
0.151
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.185 |
| BridgeBio Pharma Inc | -1.398 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.545B |
| Total Liabilities (Quarterly) | 817.50M |
| Shareholders Equity (Quarterly) | 727.68M |
| Current Ratio | 3.433 |
| Net Debt Paydown Yield | -0.81% |